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a b s t r a c t
Consistent predictors, and more especially moderators, of response to psychological treatments for
eating disorders have not been identiﬁed. The present exploratory study examined predictors and
moderators of outcome in adult patients who took part in a randomised clinical trial comparing two
leading treatments for these disorders, enhanced cognitive behavioural therapy (CBT-E) and interper-
sonal psychotherapy (IPT). Four potentially important ﬁndings emerged. Firstly, patients with a longer
duration of disorder were less likely to beneﬁt from either treatment. Second, across the two treatments
the presence, at baseline, of higher levels of over-evaluation of the importance of shape predicted a less
good treatment outcome. Third DSM-IV diagnosis did not predict treatment outcome. Fourth, with the
exception of patients with baseline low self-esteem who achieved a better outcome with CBT-E, it was
generally not possible to identify a subgroup of patients who would differentially beneﬁt from one or
other treatment.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Knowledge of the predictors of response to treatments and the
factors that moderate the effects of treatment on outcome have the
potential to lead to more precise clinical decision-making and to
promote personalised medicine (Kraemer, 2013).
While considerable progress has beenmade in the development
and evaluation of psychological treatments for eating disorders,
less is known about predictors and moderators of treatment
response. Consistent predictors, andmore especially moderators, of
response have not been identiﬁed (Agras et al., 2014; Agras, Crow,
et al., 2000; Grilo, Masheb, & Crosby, 2012; Iacovino, Gredysa,
Altman, & Wilﬂey, 2012; Le Grange et al., 2014, 2012;; Le Grange,
Crosby, & Lock, 2008; Steinhausen & Weber, 2009; Thompson-
Brenner et al., 2013; Vall & Wade, 2015).
In the present study we examined predictors and moderators of
treatment outcome in patients who took part in a randomised
controlled trial (RCT) comparing enhanced cognitive behaviour
therapy (CBT-E) and interpersonal psychotherapy (IPT) in the
treatment of adult patients with an eating disorder. Patients with
any eating disorder diagnosis were eligible provided that their body
mass index (BMI) was over 17.5 and below 40.0. There have been no
previous studies with this design. The results of this RCT indicated
that at the end of treatment the remission rate was higher among
those who had received CBT-E than IPT (CBT 65.5%; IPT 33.3%). At
60-week post-treatment follow-up the IPT remission rate had
increased to 49%, but therewas still a signiﬁcant advantage for CBT-
E with a remission rate of 69.4% (Fairburn et al., 2015). Neverthe-
less, the study demonstrated that IPT is also a viable treatment for
this large group of patients with an eating disorder.
In designing the present study we decided to focus on the
predictors and moderators of outcome at 60 weeks post-treatment
rather than on those immediately following treatment. This deci-
sion was made because it was only by this point that the effects of
IPT had been fully expressed (Fairburn et al., 2015), a ﬁnding that is
consistent with those from two earlier studies of IPT (Agras, Walsh,
Fairburn, Wilson, & Kraemer, 2000; Fairburn, Jones, Hope,
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O’Connor, & Peveler, 1993; Fairburn et al., 2015) Were we to have
focused on the patients’ state immediately after treatment, this
would have biased the ﬁndings against IPT and might have gener-
ated misleading results in terms of predicting true clinical beneﬁt.
The present study followed the recommendation of Kraemer
and colleagues (Kraemer, Wilson, Fairburn, & Agras, 2002) in
making use of an RCT to explore moderators of treatment outcome.
2. Method
2.1. Design
Predictors and moderators of treatment outcome were sought
using data from a RCT comparing CBT-E and IPT in the treatment of
adult patients with an eating disorder (Fairburn et al., 2015).
Eligible patients were randomised to either CBT-E or IPT delivered
over 20 weeks. They were then entered into a closed follow-up
period lasting 60 weeks, during which they received no addi-
tional treatment unless it was judged essential on clinical grounds.
The predictor and moderator analyses focused on the patients’
clinical state at 60-week follow-up.
2.2. Sample
Consecutive patients referred to a catchment area eating dis-
order clinic were eligible to take part if: they had a clinically sig-
niﬁcant eating disorder; were aged 18e65 years; had a BMI over
17.5 and under 40.0; and they provided written informed consent.
Exclusion criteria were: receipt of prior treatment closely resem-
bling CBT-E or IPT; a co-existing general psychiatric disorder that
precluded eating disorder-focused treatment; medical instability or
pregnancy; and not being available for treatment.
One hundred and thirty eligible participants were randomised,
65 to CBT-E and 65 to IPT. Their diagnoses were as follows: BN e 53
participants (40.8%); BED e 8 participants (6.2%); and “other eating
disorder” (OED)e 69 participants (53.1%). Details of the sample and
the CONSORT diagram are provided in the main outcome paper
(Fairburn et al., 2015).
2.3. Treatments
Both treatments were delivered in 20 50-min sessions, preceded
by one 90-min preparatory session, and followed by a review ses-
sion 20 weeks after the completion of treatment.
2.3.1. Enhanced cognitive behaviour therapy
CBT-E is designed to address eating disorder psychopathology
whatever the eating disorder diagnosis. It is personalised to match
the eating disorder psychopathology of the individual patient
(Fairburn, 2008). The default (“focused”) form of the treatment was
used, concentrating on the modiﬁcation of eating habits, weight
control behaviour and concerns about eating, shape and weight.
2.3.2. Interpersonal psychotherapy
IPT is a short-term psychological treatment designed to identify
and address current interpersonal problems (Klerman, Weissman,
Rounsaville, & Chevron, 1984). Although originally a treatment for
depression, it has been adapted to make it suitable for the treat-
ment of BN (Fairburn, 1993) and BED (Wilﬂey et al., 2002; Wilson,
Wilﬂey, Agras, & Bryson, 2010) and has been shown to be an
effective treatment for both of these conditions. The form of IPT
used in the present study has been described in detail elsewhere
(Murphy, Straebler, Basden, Cooper, & Fairburn, 2012).
2.3.3. Therapists
Treatment was provided by three therapists, two clinical psy-
chologists and a psychiatric nurse practitioner. All three had
generic clinical experience as well as experience treating eating
disorders. They received six months’ training in both treatments
from ZC and CGF prior to the start of the study and subsequent
weekly supervision (also from ZC and CGF) including the auditing
of supervisor-selected audio recordings. Further details concerning
treatment ﬁdelity and its auditing are provided in the main
outcome paper.
2.4. Assessment
2.4.1. Eating disorder features
These were assessed using the 16th edition of the Eating Dis-
order Examination interview (EDE) (Fairburn, Cooper, & O’Connor,
2008). Operational DSM-IV diagnoses of BN and BED (American
Psychiatric Association, 1994) were generated from the EDE rat-
ings, with the remaining participants being given the diagnosis of
OED. The primary (continuous) outcome used in this study was the
severity of eating disorder features as measured by the EDE global
score.
2.4.2. General psychiatric features
The Structured Clinical Interview for DSM-IV (First, Gibbon, &
Williams, 1997) was used at baseline to identify the presence of
co-existing general psychiatric disorders, and the level of depres-
sive features was measured using the Beck Depression Inventory
(BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961).
2.4.3. Weight and body mass index
Weight and height were measured at baseline. Weight was
measured using a beam balance scale and height was measured
using a wall-mounted stadiometer. BMI was calculated using these
measurements.
2.4.4. Self-esteem
The Rosenberg Self-esteem scale (RSE; (Rosenberg, 1979)) was
used to measure self-esteem at baseline.
2.4.5. Social functioning
The self-report version of the Social Adjustment Scale (SAS)
(Weissman & Bothwell, 1976) was used at baseline to assess social
role performance in several domains.
2.5. Data analysis
As recommended for moderator analyses (Wallace, Frank, &
Kraemer, 2013), we restricted the analyses to a primary outcome
used in the RCT. In order to maximise our power to detect
moderator effects we chose the continuous outcome variable, the
severity of eating disorder features, as measured by the EDE global
score. Mixed effect logistic regression models were ﬁtted with a
random effect at the individual level. Data from all time points were
included in all analyses so that the data from all participants
contributed to the analysis, even if there were missing data at
follow up. The models had the potential moderator, treatment,
time, and treatment  moderator interaction (at each time point)
and the baseline measure of the outcome as independent variables.
Moderation was considered to have occurred when a signiﬁcant
moderator  treatment interaction was found indicating that the
treatment worked differently for various levels of the moderator.
All analyses were performed in Stata.
The variables examined, ﬁrst as potential predictors and then as
moderators of outcome, were age, baseline eating disorder
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characteristics (baseline BMI, lowest adult BMI, duration of disor-
der, history of anorexia nervosa, DSM-IV diagnosis, binge eating,
self-induced vomiting, importance of shape (EDE item score),
importance of weight (EDE item score)); associated psychopa-
thology (presence of any Axis I psychiatric disorder, depression
(BDI), taking psychotropic (antidepressant) medication); self-
esteem (RSE) and social functioning (SAS). Continuous variables
were categorised to enhance their clinical relevance and to avoid
the assumption that predictors and moderators operate in a linear
fashion (Kraemer, 2016).
Despite the large number of tests conducted, a signiﬁcance cut
off of around p < 0.05 was used as a guide in interpreting our
ﬁndings. This is consistent with our aim of generating, rather than
testing hypotheses.
3. Results
3.1. Predictors of outcome
Two baseline variables were associated with the severity of
eating disorder features at 60 week follow up (see Table 1). These
were: longer duration of eating disorder and higher levels of
importance of shape. Those whose eating disorder duration at
baseline was equal to or greater than 8 years had more severe
Table 1
Predictors of outcome (Global EDE score) at 60 week follow up.
Predictor 60 week follow up
Mean difference (95% Cl) P
Age  24 0.27 (0.21,0.75) 0.27
Diagnosis (other ED/BN) 0.23 (0.72, 0.26) 0.37
History of AN 0.39 (0.15, 0.93) 0.16
Presence of binge eating e OBE 4 (1 month) 0.00 (0.63, 0.63) 0.99
Presence of self induced vomiting 4 episodes (1month) 0.16 (0.65, 0.34) 0.53
Duration of disorder  8 years 0.51 (0.03, 0.59) 0.04
Lowest BMI  19 0.02 (0.46, 0.51) 0.93
Baseline BMI  21.7 0.29 (0.19, 0.77) 0.24
Importance of weight  5 0.32 (0.18, 0.82) 0.21
Importance of shape  5 0.64 (0.11, 1.16) 0.02
Presence of any co-morbid axis 1 disorder 0.25 (0.25, 0.75) 0.33
Taking anti-depressant medication 0.07 (0.42, 5.6) 0.78
BDI  20 0.30 (0.17, 0.78) 0.21
SAS (social functioning)  1.47 0.32 (0.17, 0.81) 0.20
RSE (self-esteem)  13 0.07 (0.56, 0.43) 0.80
Table 2
Moderators of outcome at 60 week follow up.
60 week follow up
Moderator- categorical exposures Mean difference (95% Cl) p
Age <24 0.50 (1.06, 0.06) 0.18
24 0.03 (0.61, 0.56)
Diagnosis Bulimia nervosa 0.52 (1.15, 0.11) 0.27
Other Eating disorder (including BED) 0.12 (0.65, 0.42)
History of AN yes 0.54 (1.06, 0.01) 0.07
no 0.15 (0.54, 0.84)
Presence of binge eating OBE  4 (1 month) 0.11 (1.06, 0.83) 0.68
OBE < 4 (1 month) 0.32 (0.81, 0.17)
Presence of self induced vomiting SIV  4 (1 month) 0.22 (0.87, 0.42) 0.81
SIV < 4 (1 month) 0.31 (0.84, 0.22)
Duration of disorder <8 0.23 (0.79, 0.33) 0.87
8 0.29 (0.88, 0.31)
Lowest BMI <19 0.01 (0.54, 0.56) 0.09
19 0.59 (1.19, 0.02)
Baseline BMI <21.7 0.08 (0.65, 0.49) 0.27
21.7 0.47 (1.06, 0.12)
Importance of weight <5 0.27 (0.98, 0.44) 0.77
5 0.38 (0.91, 0.14)
Importance of shape <5 0.00 (0.77, 0.77) 0.27
5 0.45 (0.95, 0.04)
Presence of any co-morbid axis 1 disorder yes 0.28 (0.82, 0.25) 0.98
no 0.27 (0.94, 0.39)
Anti-depressant medication yes 0.25 (0.82, 0.33) 0.75
no 0.36 (0.95, 0.23)
Presence of any co-morbid axis 1 disorder yes 0.28 (0.82, 0.25) 0.98
no 0.27 (0.94, 0.39)
BDI <20 0.11 (0.69, 0.48) 0.35
20 0.44 (1.01, 0.13)
SAS <1.47 0.40 (0.98, 0.19) 0.36
1.47 0.07 (0.67, 0.53)
RSE <13 0.70 (1.31, 0.08) 0.03
13 0.09 (0.47, 0.66)
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eating disorder features at 60 week follow up than those who had a
disorder of shorter duration (0.51, 95% Cl 0.03, 0.59, p ¼ 0.04).
Baseline levels of importance of shape equal to 5 or 6, in contrast
with those below 5, were also associated with a greater severity of
eating disorder features at 60 weeks (0.64, 95% Cl 0.11,1.16,
p ¼ 0.02).
3.2. Moderators of outcome
The effect of CBT-E as compared to IPT on outcomewas different
depending on baseline level of self-esteem. As can be seen from
Table 2 at 60 week follow up those with low self-esteem (RSE <13)
at baseline who received CBT-E had lower scores on the severity of
eating disorder features (EDE global score) than thosewho received
IPT (0.70, 95% Cl 1.31, 0.08). For those whose baseline self
esteem scores were higher (13) there was no relative advantage
for either treatment (0.09, 95% Cl 0.47, 0.66). There were no other
baseline characteristics that identiﬁed a subgroup of patients who
differentially responded to either treatment (see Table 2).
4. Discussion
This hypothesis-generating study explored predictors and
moderators of treatment response to CBT-E and IPT in a sample of
adult patients with an eating disorder. The sample included pa-
tients with BN, BED and OED provided that their BMI was over 17.5
and below 40.0. The analyses were restricted to a primary contin-
uous outcome variable used in the RCT. The use of a single outcome
variable followed recommendations for moderator analyses
(Wallace et al., 2013) and the choice of a continuous variable was
made to maximise the power of the analyses. The outcome variable
was ‘severity of eating disorder features’ deﬁned as global EDE
score. The analyses focused on outcome at 60-week follow up as
the effects of IPT take up to 12 months after treatment to be fully
expressed. The follow-up period was closed and as a result there
was little contamination from exposure to further treatment
(Fairburn et al., 2015).
Duration of disorder and over-evaluation of the importance of
shape predicted response across the two treatments. Patients were
more likely to have eating disorder features if, at baseline, they had
a longer duration of disorder and high levels of over-evaluation of
shape.
Certain of these ﬁndings are consistent with those from other
studies. For example, lower baseline levels of over-evaluation of the
importance of shape or weight have been reported to predict
remission at the end of treatment in adults with BED (Grilo et al.,
2012) and in adolescents with BN (Le Grange et al., 2008). Over-
evaluation of the importance of shape and weight has also been
associated with the persistence of symptoms over 5 years in a
naturalistic study of BN (Fairburn et al., 2003) and to predict relapse
after remission in treated samples with BN (Fairburn, Peveler, Jones,
Hope, & Doll, 1993; Keel, Dorer, Franko, Jackson, & Herzog, 2005).
Also, in general, a longer duration of disorder and an earlier age of
onset have been associated with less good treatment outcomes at
end of treatment and at follow-up in patients with BN and BED,
although the effect sizes are small (Vall & Wade, 2015).
Only one moderator of treatment was found, indicating that for
those patients with low self-esteem CBT-E rather than IPT was
associated with a better outcome at 60 week follow up whereas for
those with higher levels of self-esteem there was no relative
advantage for either treatment. There were no other baseline
characteristics that identiﬁed a subgroup of patients who would
differentially beneﬁt from one or other treatment. The study
therefore provides little guidance for matching patients to these
two treatments.
Four potentially important ﬁndings emerge from the study.
Firstly, those with a longer duration of disorder at baseline, spe-
ciﬁcally 8 or more years, were less likely to beneﬁt from treatment.
At 60 week follow up they had higher levels of eating disorder
features as compared to those with a shorter duration of disorder at
the start of treatment. Early intervention and treatment is therefore
likely to be beneﬁcial. Second, the presence, at baseline of the
highest levels of over-evaluation of the importance of shape pre-
dicted a less good treatment outcome. This may suggest a need to
improve strategies for addressing this form of psychopathology or
perhaps point to some further features of these patients that
require investigation because of their association with a less good
outcome. Third, DSM- IV diagnosis did not predict treatment
outcome. Irrespective of whether patients received CBT-E or IPT,
eating disorder severity at 60 weeks was not determined by their
diagnostic status at baseline. This ﬁnding is consistent with a
transdiagnostic perspective on the classiﬁcation and treatment of
the eating disorders. Fourth, with one exception it was not possible
to identify patients who would differentially beneﬁt from either
treatment and therefore little guidance could be provided for
matching speciﬁc subgroups of these patients to the treatments.
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